Current Drug Metabolism

Editor-in-Chief:

Michael Sinz

Bristol Myers Squibb

Princeton, NJ

USA

 

Back

Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:19   Issue:2
Pp: 83-83
Brian Kevin Park
DOI: 10.2174/138920021902180417160519



Editorial: Efficacy, Toxicology, and PK/PD of Nanomedicine Administrated by Different Strategies free to download

Volume:19   Issue:2
Pp: 84-84
Xianwei Meng
DOI: 10.2174/138920021902180417160714



Advances in Nanostructure-mediated Hyperthermia in Tumor Therapies

Volume:19   Issue:2
Pp: 85-93
Jian-Ping Dou, Qun-Fang Zhou, Ping Liang* and Jie Yu*
DOI: 10.2174/1389200219666180129141757



Genotoxicity of Nanocarriers

Volume:19   Issue:2
Pp: 110-123
Ting Luo, Long Gao, Xiaowei Chen, Ke Xu* and Meng Niu*
DOI: 10.2174/1389200218666171031122346



Real-time Monitoring of Nanoparticle-based Therapeutics: A Review

Volume:19   Issue:2
Pp: 124-130
Qingqing Han, Meng Niu, Qirun Wu and Hongshan Zhong*
DOI: 10.2174/1389200219666180212113426



Adverse Events of Proton Pump Inhibitors: Potential Mechanisms

Volume:19   Issue:2
Pp: 142-154
Andrea Corsonello*, Fabrizia Lattanzio, Silvia Bustacchini, Sabrina Garasto, Annalisa Cozza, Roberto Schepisi, Federica Lenci, Filippo Luciani, Marcello Giuseppe Maggio, Andrea Ticinesi, Valeria Butto, Sara Tagliaferri and Francesco Corica
DOI: 10.2174/1389200219666171207125351